Geneva tests treatment for long-covid

Friday, 18 November 2022 06:30

The Geneva University Hospital is taking part in a trial to test a promising treatment for long-covid.

A Geneva biopharmaceutical company, GeNeuro, has developed an antibody which targets the persistence of inflammation after an infection.

The trial will last for 6 months and is due to start early next year. Recruitment for test subjects has already begun. Researchers are hoping for around 200 volunteers.

The results should be known in the second half of next year.

The company says long-covid is associated more with the Delta variant of covid – it seems to be less common with Omicron.

More from Bitesize News

Geneva blindsided by car tax chaos

The Geneva government has been blindsided by the effect of the new car tax and are now scrabbling to explain why.
Govt backs foie gras

The Federal Council has come down firmly on the issue of foie gras.
Fairmont to close for 3 yrs

The Geneva luxury Fairmont Hotel on the Quai Wilson will close its doors for renovation next month. The work could last for up to three years.
Long term plans for atom waste dump

The time frames are immense – but plans have been revealed on a new nuclear waste storage site, which, by law, has to be viable for a million years.
A12 closed after snow triggering crash

A section of the A12 autoroute running between Vevey and Châtel-St-Denis was closed over night following a multicar pile up, caused by the snow.
Woman seeks life saving savior

A young woman in Geneva has launched a search for the woman who saved her life when she was swept away by the Rhone last spring.